WST logo

WEST PHARMACEUTICAL SERVICES

WSTNYSE
πŸ† #467 by market capEarnings Oct 21 Β· PreUS Equity
$376.67β–² $1.02 (+0.27%)
Live
πŸ””
Track WST
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 0.3%
7dβ–² 1.4%
14dβ–² 3.3%
30dβ–² 11.9%
ytdβ–² 36.9%
1yβ–² 44.8%
🏦Market Cap
$26.51B
Mid Cap
πŸ“ˆRevenue Growth (YoY)
+6.3%
Slowing
πŸ“ŠGross Margin
36.8%
Healthy
πŸ’΅FCF Margin
13.1%
Healthy
βš–οΈP/S Ratio
7.8x
Fair
Otter Score
72
Fair

Trading Snapshot

Day Range
$371.79 – $383.65
52-Week Range
$223.83 – $386.00
Volume
$3.15B
Avg Volume
$2.65B
Shares Outstanding
70.4M
Next Earnings
Nov 28, 2026

Fundamentals Snapshot

Annual Revenue
$3.07B
Last Q Revenue
$872M
P/E Ratio
47.1
P/S Ratio
7.8x
EPS (TTM)
$7.98
Dividend Yield
0.24%
Dilution (1yr)
βˆ’1.4%

Why Investors Own WST

  • βœ“High-growth profile β€” revenue up -3.0% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 55% gross margin and 29% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

WST logo

WEST PHARMACEUTICAL SERVICES

WST
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$3.1Bβ–² +6.3% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
35.9%β–² +3.6% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$617Mβ–² +3.8% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$469Mβ–² +69.6% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
72.7Mβ–Ό βˆ’1.4% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$470Mβ–² +$288M YoY
StockOtter Β· stockotter.space

About WEST PHARMACEUTICAL SERVICES

West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
72/100

Analyst Ratings

β“˜
Consensus
Buy
23 analysts
Strong Buy7
Buy14
Hold2
Sell0
Strong Sell0
Ratings as of Sep 2026

Latest News & Updates

Zacks Investment ResearchΒ·11d ago

Reasons to Add West Pharmaceutical Stock to Your Portfolio Now

West Pharmaceutical's biologics exposure, Annex 1 projects and delivery-device growth support prospects despite near-term headwinds.

Seeking AlphaΒ·15d ago

West Pharmaceutical Services, Inc. (WST) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

West Pharmaceutical Services, Inc. (WST) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Seeking AlphaΒ·19d ago

West Pharmaceutical Services, Inc. (WST) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

West Pharmaceutical Services, Inc. (WST) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

Defense WorldΒ·19d ago

West Pharmaceutical Services, Inc. $WST Shares Sold by HB Wealth Management LLC

HB Wealth Management LLC lowered its stake in shares of West Pharmaceutical Services, Inc. (NYSE: WST) by 28.3% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC)

Defense WorldΒ·25d ago

Analyzing West Pharmaceutical Services (NYSE:WST) and Acutus Medical (NASDAQ:AFIB)

West Pharmaceutical Services (NYSE: WST - Get Free Report) and Acutus Medical (NASDAQ: AFIB - Get Free Report) are both healthcare companies, but which is the superior business? We will contrast the two companies based o

Defense WorldΒ·28d ago

Benjamin Edwards Inc. Grows Position in West Pharmaceutical Services, Inc. $WST

Benjamin Edwards Inc. grew its stake in West Pharmaceutical Services, Inc. (NYSE: WST) by 47.8% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commissi